A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN.
A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN.